Certara, Inc. (CERT)
Provides software that helps pharmaceutical companies predict how drugs will behave in the body
$8.01+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-16.0%
The outlook
CERT is trading at $8.01 with analyst consensus tilted toward Buy. The stock is positioned above both its 50- and 200-day moving averages, though it sits in the lower half of its 52-week range. The average analyst target sits roughly 6% below the current price.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range38% of the way from its 52-week low to high
Price targetAvg target -6% vs current price
Analyst price target
~12-month · 10 analysts$7.53average target-6.0% vs now
Now $8.01
Low $6.00High $10.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.25B
52-wk high
$13.88
52-wk low
$4.45
50-day avg
$5.98
200-day avg
$7.67
Trailing P/E
—